Clinical Trial Update: Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intracoronary N-acetylcysteine in patients with ST-elevation myocardial infarction undergoing primary PCI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA | Conditions: STEMI - ST Elevation Myocardial Infarction (MI), Primary PCI - STEMI | Phase 2 | Status: COMPLETED